Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.31 is 66% above its 5-year average of 2.60, near the low end of its 5-year range (0.22–15.81).
As of the fiscal period ended Friday, July 31, 2026. 39.64% above its 12-month average of 3.09.
Reported quarterly current ratio; no daily interpolation. Q3 FY2026 (2026-07-31): 4.31.
CURRENT RATIO
4.31
CURRENT RATIO AVG TTM
3.09
CURRENT RATIO AVG 3Y
1.91
CURRENT RATIO AVG 5Y
2.60
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+39.64%
CURRENT VS 3Y AVG
+125.31%
CURRENT VS 5Y AVG
+65.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 514 covered companies
CURRENT VS SECTOR MEDIAN
+28.81%
vs the sector median at left
Market Cap
$1.13M
Current Ratio
3.86
TTM Avg
3.42
3Y Avg
2.60
5Y Avg
2.60
Market Cap
$1.15M
Current Ratio
0.66
TTM Avg
1.48
3Y Avg
0.74
5Y Avg
0.53
Market Cap
$1.01M
Current Ratio
7.99
TTM Avg
0.13
3Y Avg
1.02
5Y Avg
1.02
Market Cap
$897948.00
Current Ratio
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$877747.00
Current Ratio
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clearmind Medicine Inc. (CMND) | $1.09M | 4.31 | 3.09 | 1.91 | 2.60 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | 3.86 | 3.42 | 2.60 | 2.60 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.15M | 0.66 | 1.48 | 0.74 | 0.53 |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | 0.56 | 0.67 | 0.76 | 1.51 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | 7.99 | 0.13 | 1.02 | 1.02 |
| Bone Biologics Corporation (BBLG)vs › | $897948.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.46 | 3.06 | 2.92 | 4.37 |
| Decoy Therapeutics Inc. (DCOY)vs › | $877747.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 3.00 | 0.80 | 7.12 | 9.62 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $815044.00 | 4.64 | 5.46 | 4.98 | 8.82 |
Current Ratio
4.31
Quick Ratio
4.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 4.31 |
| 2026-04-30 | 4.79 |
| 2026-01-31 | 3.79 |
| 2025-10-31 | 1.22 |
| 2025-07-31 | 1.32 |
| 2025-04-30 | 1.74 |
| 2025-01-31 | 1.72 |
| 2024-10-31 | 1.72 |
| 2024-07-31 | 1.71 |
| 2024-04-30 | 2.07 |
| 2024-01-31 | 1.96 |
| 2023-10-31 | 1.17 |
| 2023-07-31 | 2.62 |
| 2023-04-30 | 2.20 |
| 2023-01-31 | 5.58 |
| 2022-10-31 | 0.22 |
| 2022-07-31 | 1.13 |
| 2022-04-30 | 7.50 |
| 2022-01-31 | 15.81 |
| 2021-10-31 | 13.78 |
| 2021-07-31 | 15.17 |
| 2021-04-30 | 62.59 |
| 2021-01-31 | 7.56 |
| 2020-10-31 | 24.92 |
| 2020-07-31 | 27.46 |
| 2020-04-30 | 18.73 |
| 2020-01-31 | 0.05 |
| 2019-10-31 | 0.08 |
| 2019-07-31 | 0.48 |
| 2019-04-30 | 1.55 |
| 2019-01-31 | 25.63 |
| 2018-10-31 | 10.75 |
| 2018-07-31 | 2.41 |
| 2018-04-30 | 4.18 |
| 2018-01-31 | 4.22 |
| 2017-10-31 | 0.00 |
